Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

13.84

-0.35 (-2.47%)

At close: Mar 13, 2026, 4:00 PM EDT

13.70

-0.14 (-1.01%)

After-hours: Mar 13, 2026, 7:04 PM EDT

Tenax Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-52.6	-17.6	-7.71	-11.05	-32.47
Depreciation & Amortization	-	-	0.01	0.11	0.11
Stock-Based Compensation	19.16	1.13	0.19	0.37	0.77
Other Adjustments	-	0.02	0.03	0	21.35
Changes in Accounts Payable	2.88	1.06	1.65	-0.34	-0.54
Changes in Accrued Expenses	-0.42	0.52	0.24	-	-
Changes in Other Operating Activities	-4.83	0.06	-0.31	-0.48	-0.07
Operating Cash Flow	-35.8	-14.81	-5.9	-11.39	-10.86
Capital Expenditures	-	-	-	-	-0.01
Sale of Property, Plant & Equipment	-	-	0	-0	-
Purchases of Investments	-	-	-	-	-0.35
Proceeds from Sale of Investments	-	-	-	-	0.8
Investing Cash Flow	-	-	0	-0	0.45
Short-Term Debt Repaid	-	-0.5	-0.62	-	-
Net Short-Term Debt Issued (Repaid)	-	-0.5	-0.62	-	-
Issuance of Common Stock	38.51	100.37	14.19	7.93	9.74
Net Common Stock Issued (Repurchased)	38.51	100.37	14.19	7.93	9.74
Financing Cash Flow	38.51	99.87	13.57	7.93	9.74
Net Cash Flow	2.71	85.06	7.67	-3.46	-0.67
Free Cash Flow	-35.8	-14.81	-5.9	-11.39	-10.86
Free Cash Flow Per Share	-0.91	-0.97	-23.76	-619.25	-10.56
Levered Free Cash Flow	50.24	18.74	8.68	-11.76	-32.98
Unlevered Free Cash Flow	-58.75	-17.85	-6.64	-11.76	-33.23

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q